<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02906384</url>
  </required_header>
  <id_info>
    <org_study_id>ZJCH-HA-PCI</org_study_id>
    <nct_id>NCT02906384</nct_id>
  </id_info>
  <brief_title>Memory and MRI Changes With Hippocampus Avoidance Prophylactic Cranial Irradiation(HA-PCI) for Small Cell Lung Cancer(SCLC)</brief_title>
  <official_title>Memory Preservation and Functional Brain Magnetic Resonance Imaging Changes With Conformal Avoidance of the Hippocampal Neural Stem-cell Compartment During Prophylactic Cranial Irradiation for Small Cell Lung Cancer Patients: A Prospective, Randomized Phase-II Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zhejiang Cancer Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zhejiang Cancer Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, randomized phase-II study observing the memory preservation and
      functional brain MRI changes with conformal avoidance of the hippocampal neural stem-cell
      compartment during prophylactic cranial irradiation for small cell lung cancer patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Brain metastasis is rather high in small cell lung cancer patients. Prophylactic cranial
      irradiation(PCI) is the standardized treatment. However, cognitive dysfunction like memory
      damage is observed in quite a number of patients after brain irradiation, which may due to
      the hippocampus being irradiated. Thus, the investigators conduct the study by reducing the
      dose to the hippocampal neural stem-cell compartment (HAZ) during PCI.

      Patient Population: Age: 18-65y; small cell lung cancer undergoing PCI; Eastern Cooperative
      Oncology Group (ECOG) score: 0-1.

      The patients are randomized to 2 arms:

      Arm Routine PCI: PTV(planning target volume) 25Gy/10F. Arm Hippocampus avoidance PCI(HA-PCI):
      PTV 25Gray(Gy)/10Fraction(F), HAZ Dmin&lt;9Gy Dmax&lt;16Gy).

      Measurements: Hopkins verbal learning test(HVLT) and functional brain magnetic resonance
      imaging.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2016</start_date>
  <completion_date type="Anticipated">October 2020</completion_date>
  <primary_completion_date type="Anticipated">October 2018</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>memory preservation</measure>
    <time_frame>2 years</time_frame>
    <description>responses to Hopkins Verbal Learning Test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>overall survival</measure>
    <time_frame>2 years</time_frame>
    <description>Overall survival will be evaluated</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hippocampus metastasis</measure>
    <time_frame>2 years</time_frame>
    <description>hippocampus metastasis rate will be recorded</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>image changes of brain</measure>
    <time_frame>2 years</time_frame>
    <description>changes of functional brain MRI will be recorded.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">154</enrollment>
  <condition>Small Cell Lung Cancer</condition>
  <arm_group>
    <arm_group_label>routine PCI</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>PTV:25Gy/10F. Radiation technique: VMAT.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HA-PCI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PTV 25Gy/10F. Hippocampus avoidance: decrease the dose to HAZ as the following criteria: Dmin&lt;9Gy Dmax&lt;16Gy.
Radiation technique: VMAT.</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>hippocampus avoidance</intervention_name>
    <description>conformal avoidance of the hippocampal neural stem-cell compartment during prophylactic cranial irradiation</description>
    <arm_group_label>HA-PCI</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Histologically conformed small cell lung cancer;

          2. Complete response (CR)/partial response (PR) after chemo-radiotherapy;

          3. ECOG (Eastern Cooperative Oncology Group) : 0-1;

          4. No imaging evidence of brain metastasis before PCI;

          5. Normal hemodynamic indices before the recruitment (including white blood cell
             count&gt;4.0×109/L, neutrophil count&gt;1.5×109/L, platelet count &gt;100×109/L,
             hemoglobin≥90g/l, normal liver/kidney function);

          6. Able to understand this study and have signed informed consent.

        Exclusion Criteria:

          1. Unable to receive MRI;

          2. Medical history of central nervous system, cognitive or psychological diseases;

          3. The expectation of life is less than 6 months;

          4. Female in pregnancy or lactating;

          5. The researchers consider the patient not appropriate to be enrolled.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ming Chen, PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zhejiang Cancer Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yue Kong</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zhejiang Cancer Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ming Chen, PHD</last_name>
    <phone>0086-571-88122068</phone>
    <email>chenming@zjcc.org.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yue Kong</last_name>
    <phone>0086-571-88128172</phone>
    <email>kongyue@zjcc.org.cn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Zhejiang Cancer Hospital</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>310022</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ming Chen, PHD</last_name>
      <email>chenming@zjcc.org.cn</email>
    </contact>
    <investigator>
      <last_name>Ming Chen, PHD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 9, 2016</study_first_submitted>
  <study_first_submitted_qc>September 19, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 20, 2016</study_first_posted>
  <last_update_submitted>October 6, 2016</last_update_submitted>
  <last_update_submitted_qc>October 6, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 10, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>hippocampus avoidance</keyword>
  <keyword>volumetric modulated arc therapy</keyword>
  <keyword>functional MRI</keyword>
  <keyword>hopkins Verbal Learning Test</keyword>
  <keyword>prophylactic cranial irradiation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Small Cell Lung Carcinoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

